{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:34:49Z","timestamp":1792175689846,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Ability Establishment of Sustainable Use for Valuable Chinese medicine Resources","award":["2060302"],"award-info":[{"award-number":["2060302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Ulcerative Colitis (UC) is a chronic nonspecific inflammatory disease of the colon and rectum. Fructus Mume (FM) and Rhizoma Coptidis (RC) exert effects on inflammatory and immune diseases. We evaluated the hypothesis of the FM and RC (FM-RC) herb pair remedy in alleviating dextran sulfate sodium (DSS)-induced colitis, through network pharmacology-based analyses, molecular docking, and experimental validation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Traditional Chinese medicine systematic pharmacology analysis platform(TCMSP) and Swiss database were used to predict potential targets of FM-RC and the GeneCards database was utilized to collect UC genes. Cytoscape software was used to construct and analyze the networks, and DAVID was utilized to perform enrichment analysis. AutoDock software was used to dock the core chemical components of the FM-RC herb pair with key UC targets. Animal experiments were performed to validate the prediction results and general conditions and body weight were observed. Pathological changes in colon tissue were observed by staining with hematoxylin and eosin. The levels of TNF-\u03b1, IL-8, IL-17, and IL-4 in serum and colon tissue were detected by ELISA. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighteen effective components of the herb couple were screened, and their potential therapeutic targets in the treatment of UC were acquired from 110 overlapped targets. GO and KEGG analyses revealed that these targets were highly correlated with protein autophosphorylation, plasma membrane, ATP binding, cancer pathways, the PI3K-AKt signaling pathway, and the Rap1 signaling pathway. Molecular docking established the core protein interactions with compounds having a docking energy\u2009&lt;\u20090\u00a0kJ\u00b7mol<jats:sup>\u22121<\/jats:sup>, indicating the core active components had strong binding activities with the core targets. FM-RC herb pair relieved pathological indicators and reduced the concentration of TNF-\u03b1, IL-8, and IL-17  and increased IL-4 levels in the serum and colon tissues of UC rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Collectively, FM-RC herb pair administration alleviated UC. These beneficial effects targeted MAPK1 signaling related to inflammation and immunity, which provided a basis for a better understanding of FM-RC in the treatment of UC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-022-03823-7","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:02:54Z","timestamp":1673848974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology"],"prefix":"10.1186","volume":"23","author":[{"given":"Yatian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"3823_CR1","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/DDDT.S319786","volume":"15","author":"JQ Liu","year":"2021","unstructured":"Liu JQ, Liu J, Tong XL, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Des Devel Ther. 2021;15:3255\u201376.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3823_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jbcpp-2018-0036","volume":"30","author":"N Tatiya-Aphiradee","year":"2018","unstructured":"Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K. Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol. 2018;30(1):1\u201310.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"48","key":"3823_CR3","doi-asserted-by":"publisher","first-page":"8242","DOI":"10.3748\/wjg.v27.i48.8242","volume":"27","author":"JK Yamamoto-Furusho","year":"2021","unstructured":"Yamamoto-Furusho JK, Parra-Holgu\u00edn NN. Emerging therapeutic options in inflammatory bowel disease. World J Gastroenterol. 2021;27(48):8242\u201361.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3823_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.cgh.2021.01.028","volume":"19","author":"PA Laurain","year":"2021","unstructured":"Laurain PA, Guillo L, D\u2019Amico F, et al. Incidence of and risk factors for colorectal strictures in ulcerative colitis: a multicenter study. Clin Gastroenterol H. 2021;19(9):1899.","journal-title":"Clin Gastroenterol H"},{"issue":"3","key":"3823_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/cancers14030530","volume":"14","author":"CG Le","year":"2022","unstructured":"Le CG, Buscail E, Gilletta C, et al. Incidence and risk factors of cancer in the anal transitional zone and Ileal pouch following surgery for ulcerative colitis and familial adenomatous polyposis. Cancers. 2022;14(3):530.","journal-title":"Cancers"},{"issue":"3","key":"3823_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11864-014-0288-2","volume":"15","author":"M Sa\u0142aga","year":"2014","unstructured":"Sa\u0142aga M, Zatorski H, Sobczak M, et al. Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review. Curr Treat Option On. 2014;15(3):405\u201320.","journal-title":"Curr Treat Option On"},{"issue":"1","key":"3823_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-018-2420-5","volume":"19","author":"Y Xueping","year":"2019","unstructured":"Xueping Y, Fuer L, Lingli L, et al. Wu-Mei-wan protects pancreatic \u03b2 cells by inhibiting NLRP3 Inflammasome activation in diabetic mice. BMC Complementary Altern Med. 2019;19(1):1\u201312.","journal-title":"BMC Complementary Altern Med"},{"issue":"1","key":"3823_CR8","first-page":"020028","volume":"2079","author":"D Xiaojie","year":"2019","unstructured":"Xiaojie D, Xiling S, Xiaofei Y, et al. The effects of wumei pill on intestinal flora and neurotransmitters in rats with diarrhea-predominant irritable bowel syndrome (IBS-D). AIP Conf Proc. 2019;2079(1):020028.","journal-title":"AIP Conf Proc"},{"issue":"C","key":"3823_CR9","first-page":"109982","volume":"125","author":"J Feng","year":"2020","unstructured":"Feng J, Minghao L, Haidan W, et al. Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-kB\/IL6-STAT3 signaling pathway. Biomed Pharmacother. 2020;125(C):109982.","journal-title":"Biomed Pharmacother"},{"key":"3823_CR10","doi-asserted-by":"crossref","unstructured":"Ding XJ, Sun XL, Wang ZE, et al. The Effects of Wumei Pill on TLRs\/NF-kB signaling pathway in rats with diarrhea-predominant irritable bowel syndrome. Pak J Zool. 2018;51(1):57\u201365.","DOI":"10.17582\/journal.pjz\/2019.51.1.57.65"},{"issue":"6","key":"3823_CR11","first-page":"538","volume":"30","author":"Q Wang","year":"2014","unstructured":"Wang Q, Liu SL, Yan SH, et al. Effect of the Wumei Huanglian Fang on HT29 proliferation and migration of human colon cancer cell. J Nanjing Univ Chin Med. 2014;30(6):538\u201341.","journal-title":"J Nanjing Univ Chin Med"},{"issue":"11","key":"3823_CR12","first-page":"2346","volume":"31","author":"HX Zhu","year":"2013","unstructured":"Zhu HX, Wang Q, Liu SL, et al. Experimental study on anti-proliferation effect of Wumei Huanglian Compound on human colon cancer cell line Lovo and HT29. J Chin Med. 2013;31(11):2346\u20138.","journal-title":"J Chin Med"},{"issue":"11","key":"3823_CR13","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jssc.202101002","volume":"45","author":"R Wang","year":"2022","unstructured":"Wang R, Cheng H, Yang YT, et al. Ultra-performance liquid chromatography-quadrupole-time of flight tandem-mass spectrometry and liquid chromatograph-tandem mass spectrometer combined with chemometric analysis an approach for the quality evaluation of Mume Fructus. J Sep Sci. 2022;45(11):1884\u201393.","journal-title":"J Sep Sci"},{"issue":"1","key":"3823_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/13880209.2019.1577466","volume":"57","author":"J Wang","year":"2019","unstructured":"Wang J, Wang L, Lou GH, et al. Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol. 2019;57(1):193\u2013225.","journal-title":"Pharm Biol"},{"issue":"10","key":"3823_CR15","first-page":"195","volume":"14","author":"X Jiang","year":"2012","unstructured":"Jiang X, Li SS, Zhang B, et al. Study on fingerprint of different compatibility ratio of Rhizoma coptidis-Fructus mume. J Liaoning Univ Chin Med. 2012;14(10):195\u20137.","journal-title":"J Liaoning Univ Chin Med"},{"issue":"05","key":"3823_CR16","first-page":"357","volume":"30","author":"AM He","year":"2012","unstructured":"He AM, Wang YL, Lin SM. The effect of Fructus Mume decoction on rat with experimental ulcerative colitis. J Pharm Pract. 2012;30(05):357\u201360.","journal-title":"J Pharm Pract"},{"issue":"40","key":"3823_CR17","doi-asserted-by":"publisher","first-page":"e22457","DOI":"10.1097\/MD.0000000000022457","volume":"99","author":"TL Li","year":"2020","unstructured":"Li TL, Wu MZ, Wang LZ, et al. Huang Lian for ulcerative colitis A protocol of systematic review and meta-analysis of randomized clinical trials. Medicine. 2020;99(40):e22457.","journal-title":"Medicine"},{"key":"3823_CR18","doi-asserted-by":"publisher","first-page":"5418142","DOI":"10.1155\/2021\/5418142","volume":"2021","author":"YK Du","year":"2021","unstructured":"Du YK, Xiao Y, Zhong SM, et al. Study on the mechanism of Acori Graminei Rhizoma in the treatment of Alzheimer\u2019s Disease based on network pharmacology and molecular docking. Biomed Res Int. 2021;2021:5418142.","journal-title":"Biomed Res Int"},{"key":"3823_CR19","doi-asserted-by":"publisher","first-page":"796757","DOI":"10.3389\/fcell.2021.796757","volume":"9","author":"GF Jia","year":"2021","unstructured":"Jia GF, Jiang XX, Li ZQ, et al. Decoding the mechanism of Shen Qi Sha Bai decoction in treating acute myeloid leukemia based on network pharmacology and molecular docking. Front Cell Dev Biol. 2021;9:796757.","journal-title":"Front Cell Dev Biol"},{"key":"3823_CR20","doi-asserted-by":"publisher","first-page":"761980","DOI":"10.3389\/fphar.2021.761980","volume":"12","author":"MF Zhou","year":"2021","unstructured":"Zhou MF, Li JX, Luo D, et al. Network pharmacology and molecular docking-based investigation: Prunus mume against colorectal cancer via silencing RelA expression. Front Pharmacol. 2021;12:761980.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3823_CR21","doi-asserted-by":"publisher","first-page":"20849","DOI":"10.1038\/s41598-021-00293-8","volume":"11","author":"WR An","year":"2021","unstructured":"An WR, Huang YQ, Chen SQ, et al. Mechanisms of Rhizoma Coptidis against type 2 diabetes mellitus explored by network pharmacology combined with molecular docking and experimental validation. Sci Rep. 2021;11(1):20849.","journal-title":"Sci Rep"},{"issue":"12","key":"3823_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11655-020-3422-y","volume":"27","author":"LN Yang","year":"2021","unstructured":"Yang LN, Wu ZL, Yang ZJ, et al. Exploring mechanism of key Chinese herbal medicine on breast cancer by data mining and network pharmacology methods. Chin J Integr Med. 2021;27(12):919\u201326.","journal-title":"Chin J Integr Med"},{"issue":"06","key":"3823_CR23","first-page":"33","volume":"12","author":"Z Wei","year":"2021","unstructured":"Wei Z, Huang LM. Potential mechanism of Danggui Buxue decoction in treating iron deficiency anemia based on network pharmacology and molecular docking technology. Med Plant. 2021;12(06):33\u20136.","journal-title":"Med Plant"},{"issue":"2","key":"3823_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110\u201320.","journal-title":"Chin J Nat Med"},{"key":"3823_CR25","first-page":"6629761","volume":"2021","author":"SX Liu","year":"2021","unstructured":"Liu SX, et al. Uncovering the Mechanism of curcuma in the treatment of ulcerative colitis based on network pharmacology, molecular docking technology, and experiment verification. Evid Based Complement Alternat Med. 2021;2021:6629761.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"13","key":"3823_CR26","first-page":"5581","volume":"23","author":"S Paolacci","year":"2019","unstructured":"Paolacci S, Precone V, Acquaviva F, et al. Genetics of lipedema:new perspectives on genetic research and molecular diagnoses. Eur Rev Med Pharmacol Sci. 2019;23(13):5581\u201394.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3823_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat commun. 2019;10(1):1523.","journal-title":"Nat commun"},{"issue":"prepublish","key":"3823_CR28","doi-asserted-by":"publisher","first-page":"154002","DOI":"10.1016\/j.phymed.2022.154002","volume":"99","author":"ZH Liu","year":"2022","unstructured":"Liu ZH, Peng Y, Ma P, et al. An integrated strategy for anti-inflammatory quality markers screening of traditional Chinese herbal medicine Mume Fructus based on phytochemical analysis and anti-colitis activity. Phytomedicine. 2022;99(prepublish):154002.","journal-title":"Phytomedicine"},{"key":"3823_CR29","doi-asserted-by":"publisher","first-page":"3498310","DOI":"10.1155\/2022\/3498310","volume":"2022","author":"SQ Niu","year":"2022","unstructured":"Niu SQ, Jing MY, Wen JX, et al. Jatrorrhizine Alleviates DSS-induced ulcerative colitis by regulating the intestinal barrier function and inhibiting TLR4\/MyD88\/NF-\u03baB signaling pathway. Evid Based Complement Alternat Med. 2022;2022:3498310\u20133498310.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3823_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molimm.2018.10.015","volume":"105","author":"TM Chu","year":"2019","unstructured":"Chu TM, Mei MW, Chun LW, et al. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation. Mol Immunol. 2019;105:76\u201385.","journal-title":"Mol Immunol"},{"issue":"PA","key":"3823_CR31","doi-asserted-by":"publisher","first-page":"108329","DOI":"10.1016\/j.intimp.2021.108329","volume":"101","author":"C Zheng","year":"2021","unstructured":"Zheng C, Wang YM, Xu YJ, et al. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis. Int Immunopharmacol. 2021;101(PA):108329\u2013108329.","journal-title":"Int Immunopharmacol"},{"key":"3823_CR32","doi-asserted-by":"publisher","first-page":"6678662","DOI":"10.1155\/2021\/6678662","volume":"2021","author":"H Yi","year":"2021","unstructured":"Yi H, Peng HY, Wu XY, et al. The therapeutic effects and mechanisms of quercetin on metabolic diseases: pharmacological data and clinical evidence. Oxid Med Cell Longev. 2021;2021:6678662.","journal-title":"Oxid Med Cell Longev"},{"issue":"02","key":"3823_CR33","first-page":"47","volume":"10","author":"XL Ye","year":"2021","unstructured":"Ye XL, Zheng YZ, Qiu ZW, et al. The mechanism of quercetin in the treatment of rheumatoid arthritis. Rheu Arthr. 2021;10(02):47\u201350+54.","journal-title":"Rheu Arthr"},{"issue":"1","key":"3823_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ijms22010217","volume":"22","author":"P Rajendran","year":"2020","unstructured":"Rajendran P, Ammar RB, AlSaeedi FJ, et al. Kaempferol inhibits Zearalenone-induced oxidative stress and apoptosis via the PI3K\/Akt-Mediated Nrf2 signaling pathway: in vitro and in vivo studies. Int J Mol Sci. 2020;22(1):217.","journal-title":"Int J Mol Sci"},{"key":"3823_CR35","unstructured":"Ou RL. The effect and mechanism of kaempferol in chemoprevention of colorectal cancer. Guangzhou Univ Chin Med. 2016;05:1\u2013108."},{"issue":"4","key":"3823_CR36","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/15548627.2019.1632122","volume":"16","author":"S Zhang","year":"2020","unstructured":"Zhang S, Yang Z, Bao W, et al. SNX10 (sorting nexin 10)inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC. Autophagy. 2020;16(4):735\u201349.","journal-title":"Autophagy"},{"issue":"03","key":"3823_CR37","first-page":"293","volume":"38","author":"Q Zeng","year":"2021","unstructured":"Zeng Q, Nie MH. Research progress on the role of Src kinase in tumor invasion and metastasis. J Xinxiang Med Coll. 2021;38(03):293\u20135+300.","journal-title":"J Xinxiang Med Coll"},{"key":"3823_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.micpath.2019.02.030","volume":"130","author":"Y Chen","year":"2019","unstructured":"Chen Y, Lu S, Zhang Y, et al. TLR2 agonist Pam3CSK4 enhances the antibacterial functions of GM-CSF induced neutrophils to methicillin-resistant staphylococcus aureus. Microb Pathog. 2019;130:204\u201312.","journal-title":"Microb Pathog"},{"issue":"26","key":"3823_CR39","first-page":"102","volume":"60","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang H. Research progress on signaling pathways related to the anti-inflammatoryeffect of Annexin A1. Shandong Med. 2020;60(26):102\u20135.","journal-title":"Shandong Med"},{"issue":"1","key":"3823_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12906-015-0652-1","volume":"15","author":"KM Lee","year":"2015","unstructured":"Lee KM, Bang JH, Kim BY, et al. Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling. BMC Complement Altern Med. 2015;15(1):125.","journal-title":"BMC Complement Altern Med"},{"issue":"03","key":"3823_CR41","first-page":"183","volume":"28","author":"Y Bai","year":"2021","unstructured":"Bai Y, Wu LL, An JD, et al. Correlation between KRAS, NRAS, BRAF, PIK3CA gene mutations and clinicopathological features and expression of MMR protein and p53 protein in colorectal cancer tissues. J Dign Pathol. 2021;28(03):183\u20138+193.","journal-title":"J Dign Pathol"},{"key":"3823_CR42","unstructured":"Zhan JY, Yuan XX, Wang BY, et al. Effects of Liancao Xieli capsule on intestinal mucosal inflammatory factors and TLR4\/ PI3K\/ Akt\/ mTOR signaling pathway in ulcerative colitis mouse model. J Hainan Med Coll. 2021;27(24):1872\u20137."},{"issue":"11","key":"3823_CR43","first-page":"1406","volume":"189","author":"RX Zhang","year":"2014","unstructured":"Zhang RX, Fu YJ, Liang JZ, et al. Berberine in the treatment of immune complex ulcerative colitis and down-regulation of inflammatory cytokines in rats. Clin Med Engin. 2014;189(11):1406\u20139.","journal-title":"Clin Med Engin"},{"issue":"2","key":"3823_CR44","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3892\/etm.2021.10240","volume":"22","author":"JS Park","year":"2021","unstructured":"Park JS, Park H, Lee YL, et al. Blocking TNF-\u03b1 attenuates progressive cartilage matrix degradation in inflammatory arthritis. Exp Ther Med. 2021;22(2):808.","journal-title":"Exp Ther Med"},{"issue":"07","key":"3823_CR45","first-page":"1045","volume":"36","author":"BL Li","year":"2019","unstructured":"Li BL, Zhao DY, Du PL, et al. Effects of Huazhuo Jiedu Fang on serum IL-1\u03b2, IL-8 content and expression of NF-\u03baB mRNA in colonic mucosa in rats with ulcerative colitis. J Guangzhou Univ Chin Med. 2019;36(07):1045\u20139.","journal-title":"J Guangzhou Univ Chin Med"},{"issue":"08","key":"3823_CR46","first-page":"946","volume":"37","author":"XL Si","year":"2021","unstructured":"Si XL, Wang Y, Wang Z, et al. Effects of paeoniflorin on the expression of IL-17 in DSS-induced chronic ulcerative colitis in rats. Chin J Immunol. 2021;37(08):946\u201350.","journal-title":"Chin J Immunol"},{"key":"3823_CR47","doi-asserted-by":"publisher","first-page":"9970240","DOI":"10.1155\/2021\/9970240","volume":"2021","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhao L, Chen Q, et al. Exploring the mechanism of Berberine intervention in ulcerative colitis from the perspective of inflammation and immunity based on systemic pharmacology. Evid Based Complement Alternat Med. 2021;2021:9970240.","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-022-03823-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:04:20Z","timestamp":1673849060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-022-03823-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3823"],"URL":"https:\/\/doi.org\/10.1186\/s12906-022-03823-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"12 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care and experimental procedures performed in this study were approved\u00a0by the Animal Ethics Committee of Anhui University of Chinese Medicine (2022004). We confrm that all methods were performed in accordance with relevant guidelines and regulations. We also confrm that the study was carried out in compliance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}